The Molecular Key to the Theta Field: A Zero-Parameter Formalization of Endogenous DMT and Consciousness State Transitions

Summary

N,N-dimethyltryptamine (DMT) is linked to neuroprotection and near-death experience (NDE) phenomenology through a new framework that integrates its pharmacology with mathematical models. The study presents testable predictions, including that DMT will increase EEG power at approximately 8.09 Hz and that tryptamine analogs will show specific coupling/control ratios. This approach connects the neuroprotective effects of DMT with its consciousness-altering properties, suggesting they are fundamentally similar.

Study at a glance

Abstract

N,N-dimethyltryptamine (DMT) is an endogenous tryptamine neurotransmitter whose extracellular concentrations rival serotonin, whose release increases during cardiac arrest, and whose sigma-1 receptor (Sig-1R) activation provides potent neuroprotection against hypoxia. Despite decades of research, no first-principles framework explains why the brain synthesizes a molecule that produces near-death experience phenomenology, nor connects its neuroprotective and consciousness-altering functions within a single mechanism. We integrate DMT pharmacology into the machine-verified Recognition Science (RS) framework using 17 new Lean 4 modules. This paper explicitly distinguishes between the mathematically forced core of the framework and the phenomenological models built upon it. The logical structure follows a rigorous chain: Forced Structure: The Recognition Composition Law (RCL) forces the existence of the φ-ladder, the J-cost function, and the universal theta field (Θ). Modeling Interpretation: We map specific biological components to this forced structure: DMT is identified with the φ¹ ladder rung, yielding a "golden balance" (coupling multiplier × control factor = 1); Sigma-1 receptor activation is modeled as lowering the cellular J-cost barrier; and NDE phenomenology is injectively mapped to theta-field geometry. Testable Consequences: This model generates specific, falsifiable predictions: (a) DMT will preferentially amplify EEG power at 5φ ≈ 8.09 Hz; (b) Faraday shielding will attenuate inter-subject theta coherence; (c) tryptamine analogs (e.g., 4-HO-DMT) will exhibit coupling/control ratios at discrete φ-ladder half-rungs. The Lean 4 formalization verifies the strict logical consistency of our biological model with the underlying physics, demonstrating that neuroprotection and NDE phenomenology are mathematically identical operations on the tether channel.

Tags